Mundipharma market exit
Mundipharma advised that it is leaving the Aotearoa New Zealand market.
1 May 2024 update
Stock availability updated for oxycodone products.
Products we're still seeking a resolution for
| Chemical name | Stock available until* | Presentation | Brand | Pharmacode | Update |
|---|---|---|---|---|---|
| Dihydrocodeine tartrate | June 2025 | Tab long-acting 60 mg | DHC Continus | 772887 | We are in discussion with a supplier |
| Oxycodone hydrochloride | mid July 2024 | cap 5 mg Immediate release | OxyNorm | 2179741 | OxyNorm Medicine notice |
| Oxycodone hydrochloride | mid May 2024 | cap 10 mg immediate release | OxyNorm | 2179768 | OxyNorm Medicine notice |
| Oxycodone hydrochloride | early Sept 2024 | cap 20 mg immediate release | OxyNorm | 2179776 | OxyNorm Medicine notice |
| Oxycodone hydrochloride | late May 2024 | oral liq 5 mg per 5 ml | OxyNorm | 2243687 | OxyNorm Medicine notice |
| Morphine sulphate | June 2025 | Tab immediate-release 10 mg | Sevredol | 2520990 | Tender declined |
| Morphine sulphate | June 2025 | Tab immediate-release 20 mg | Sevredol | 2521008 | Tender declined |
* This is the date stock will likely run out with the supplier, stock will remain in the supply chain for another week or two after this date.
Oxycodone and morphine
We are talking to suppliers to ensure the continued supply of these products. We would welcome any information from suppliers about supply options. Suppliers can email ContractManagement@pharmac.govt.nz
Items being delisted
| Chemical name | Presentation | Brand | Pharmacode | Resolution |
|---|---|---|---|---|
| Timolol | Eye drops 0.5%, gel forming | Timoptol XE | 204374 |
Restricted to no new patients 1 April 2023. Delisted 1 March 2024 |
| Dorzolamide hydrochloride | Eye drops 2% | Trusopt | 285226 |
Restricted to no new patients 1 April 2023. Delisted 1 March 2024 |
What Pharmac is doing
Pharmac is considering multiple options for products currently supplied by Mundipharma. We will update this page with information about what is happening with each product.
We are working closely with Mundipharma and other suppliers to ensure as little disruption as possible for people using Mundipharma's products.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)